Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ImmunoGen, Inc. | imgn-20170331ex312a26405.htm |
| EX-31.1 - EX-31.1 - ImmunoGen, Inc. | imgn-20170331ex3114f478e.htm |
| EX-10.9 - EX-10.9 - ImmunoGen, Inc. | imgn-20170331ex1099a4c54.htm |
| EX-10.8 - EX-10.8 - ImmunoGen, Inc. | imgn-20170331ex10851101e.htm |
| EX-10.7 - EX-10.7 - ImmunoGen, Inc. | imgn-20170331ex1070bfcc3.htm |
| EX-10.6 - EX-10.6 - ImmunoGen, Inc. | imgn-20170331ex106ed231d.htm |
| EX-10.5 - EX-10.5 - ImmunoGen, Inc. | imgn-20170331ex105352b3e.htm |
| EX-10.4 - EX-10.4 - ImmunoGen, Inc. | imgn-20170331ex104e6d1b2.htm |
| EX-10.3 - EX-10.3 - ImmunoGen, Inc. | imgn-20170331ex103494a5c.htm |
| EX-10.2 - EX-10.2 - ImmunoGen, Inc. | imgn-20170331ex10242595c.htm |
| 10-Q - 10-Q - ImmunoGen, Inc. | imgn-20170331x10q.htm |
EXHIBIT 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the period ended March 31, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: May 5, 2017 |
/s/MARK J. ENYEDY |
|
|
Mark J. Enyedy |
|
|
President, Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
|
Dated: May 5, 2017 |
/s/ DAVID B. JOHNSTON |
|
|
David B. Johnston |
|
|
Executive Vice President, Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |